Cardiff Oncology, Inc.CRDFNASDAQ

Revenue (LTM)

$593000

-13.2% YoY

Net Income (LTM)

$-46M

-1.0% YoY

Free Cash Flow

$-38M

Revenue CAGR (5Y)

+13.4%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0↑7.5%	0↑26.4%	1↑40.0%	1↓13.2%
Gross Profit	0	0↑7.5%	0↑26.4%	1↑40.0%	-0↓145.5%
Operating Income	-29	-40↓38.3%	-45↓13.8%	-49↓7.1%	-49↓0.6%
Net Income	-28	-39↓36.8%	-41↓7.1%	-45↓9.6%	-46↓1.0%
EBITDA	-28	-40↓39.6%	-45↓13.5%	-48↓7.2%	-45↑6.8%
EPS Diluted	-0.73	-0.89↓21.9%	-0.93↓4.5%	-0.95↓2.2%	-0.69↑27.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	12	16↑36.9%	22↑32.5%	51↑137.7%	17↓66.1%
Total Current Assets	146	111↓23.8%	77↓30.4%	95↑22.8%	60↓36.7%
Total Assets	150	116↓22.3%	82↓29.7%	97↑19.1%	62↓36.3%
Total Current Liabilities	7	8↑19.0%	10↑33.7%	13↑28.6%	16↑22.1%
Total Liabilities	9	10↑7.9%	12↑20.8%	14↑19.7%	16↑15.8%
Total Equity	140	106↓24.3%	70↓34.4%	83↑18.9%	45↓45.3%
Total Debt	3	3↓13.0%	2↓20.8%	2↓29.1%	1↓45.4%
Net Debt	-9	-14↓54.5%	-20↓43.1%	-50↓156.1%	-17↑66.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-23	-34↓46.8%	-31↑8.7%	-38↓22.0%	-38↓0.6%
Capital Expenditure	-0	-1↓335.1%	-1↑34.8%	-0↑86.3%	-0↑45.0%
Free Cash Flow	-23	-35↓49.3%	-31↑9.3%	-38↓20.0%	-38↓0.5%
Stock-Based Comp	3	4↑31.6%	5↑5.9%	5↑5.6%	6↑19.6%
Net Change in Cash	-119	4↑103.7%	5↑20.5%	30↑461.7%	-34↓214.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance